IP Library Granted Patent US 8,231,903
Granted Patent B2
US 8,231,903 · App. 11/243,293 · Granted Jul 31, 2012

Controlled release system

Assignee: Bayer Animal Health GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,231,903
App. No.
11/243,293
Granted
Jul 31, 2012
Kind
B2
Abstract

The invention relates to a system for controlled release of medicinally active substances, which comprises sucrose acetate isobutyrate (SAIB) and a further solvent.

Claims (6)

1. An injectable medicament comprising:

a. Pradofloxacin, wherein the pradofloxacin is in an amount of 5 to 15% by weight based on the total weight of the medicament;

b. sucrose acetate isobutyrate (SAIB), wherein the SAIB is in an amount of 10 to 75% by weight based on the total weight of the medicament;

c. a solvent selected from the group consisting of glycerol formal, isopropylideneglycerol, and a mixture thereof, and

d. a cosolvent, wherein the cosolvent is selected from the group consisting of ethanol, n-butanol, and benzyl alcohol and is in an amount of 1 to 10% by weight based on the total weight of the medicament.

2. The medicament according to claim 1 , wherein the solvent is glycerol formal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2013
From: BAYER ANIMAL HEALTH GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030127/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2005
From: FRAATZ, KRISTINE; MERTIN, DIRK; HEEP, IRIS
To: BAYER HEALTHCARE AG
Reel/Frame 017224/0117 →
Priority Claims (1)
DE 103 12 346 · Mar 20, 2003 · national
Continuity (3)
Continuation PCTEP2004002318 · Mar 6, 2004
Related Publication 20060034926A1 · Feb 16, 2006
Related Publication 20090246277A9 · Oct 1, 2009